Multiple sclerosis relapse

• Concentration of ofatumumab in the breast milk of lactating women with relapsing forms of multiple sclerosis Recruiting
  2023-505283-11-00 6 2024-12-10 "Relapsing forms of Multiple Sclerosis (RMS)"
• Comparative PK, PD, efficacy, safety and immunogenicity assessment of the proposed ocrelizumab biosimilar CYB704 and Ocrevus in participants … Recruitment ended
  2024-512319-40-00 5 2025-07-01 "Subjects with relapsing multiple sclerosis (relapsing remitt"
• A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults with Relapsing Multiple Sclerosis Recruitment ended
  2023-506467-34-00 5 2020-10-20 "Relapsing Multiple Sclerosis (MS)"
• An open-label extension study evaluating long-term safety, tolerability and effectiveness of ofatumumab in subjects with RMS Recruitment ended
  2023-507906-15-00 5 2019-01-30 "Relapsing multiple sclerosis (RMS)"
• Study of efficacy and tolerability of ofatumumab vs. First Line disease modifying treatment (DMT) - physician’s choice in the treatment of n … Ended
  2023-507431-37-00 5 2021-07-23 "relapsing multiple sclerosis (RMS)"
• An open-label study evaluating ofatumumab treatment effectiveness and PROs in subjects with RMS transitioning from fumarate-based RMS approv … Ended
  2023-507493-41-00 5 2020-08-04 "relapsing multiple sclerosis (RMS)"
• A Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Patients with Multiple Sclerosis Previously Enrolled in A F. Hoffmann-la … Ended
  2023-506543-41-00 5 2018-07-25 "Multiple sclerosis (MS)"

Showing 1–7 of 7 trials